Diagnosis and treatment of portal hypertension.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Digestive and Liver Disease

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.DLD.2004.08.001PMID 15646423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.

  2004cited by this paper
• The hepatic venous pressure gradient: Anything worth doing should be done right

  2004cited by this paper
• Hypertension: pathophysiology and treatment

  2004cited by this paper
• Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: A double‐blind RCT

  2003cited by this paper
• Cirrhosis and bleeding: the need for very early management.

  2003cited by this paper
• 127 Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial

  2003cited by this paper
• Improved Patient Survival After Acute Variceal Bleeding: A Multicenter, Cohort Study

  2003cited by this paper
• Efficacy of activated recombinant factor VII (RFVIIA; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: A randomised placebo-controlled double-blind multicenter trial

  2003cited by this paper
• 128 Endoscopic banding ligation versus propranolol for the primary prevention of variceal bleeding in cirrhosis: a randomized controlled multicenter trial

  2003cited by this paper
• 103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor

  2003cited by this paper
• Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators

  2003cited by this paper
• Post-Shunt Resource Consumption Favors Small-Diameter Prosthetic H-Graft Portacaval Shunt Over TIPS for Patients With Poor Hepatic Reserve

  2003cited by this paper
• Incidence and natural history of small esophageal varices in cirrhotic patients.

  2003cited by this paper
• Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta‐analysis

  2002cited by this paper
• Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study.

  2002cited by this paper
• Endoscopic screening for esophageal varices in cirrhotic patients

  2002cited by this paper
• Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of the first bleeding in cirrhosis. A double-blind placebo-controlled randomised trial

  2002cited by this paper
• Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.

  2002cited by this paper
• Salvage tips for uncontrolled variceal bleeding.

  2002cited by this paper
• “A la carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

  2002cited by this paper
• Prophylactic banding ligation of high risk esophageal varices inpatients on the waiting list for liver transplantation: an interim report

  2002cited by this paper
• Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding.

  2002cited by this paper
• A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

  2002cited by this paper
• Prediction of Esophageal Varices in Patients With Cirrhosis

  2002cited by this paper
• Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.

  2002cited by this paper
• Recombinant Activated Factor VII (rFVIIa) Acutely Normalizes Prothrombin Time in Patients with Cirrhosis During Bleeding from Oesophageal Varices

  2001cited by this paper
• Effects of blood volume restitution following a portal hypertensive–related bleeding in anesthetized cirrhotic rats

  2001cited by this paper
• Diagnosis of Portal Hypertension: How and When

  2001cited by this paper
• Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when.

  2001cited by this paper
• Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

  2001cited by this paper
• Natural history of portal hypertension in patients with cirrhosis.

  2001cited by this paper
• Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.

  2001cited by this paper
• Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding.

  2001cited by this paper
• Presence of Bacterial Infection in Bleeding Cirrhotic Patients Is Independently Associated with Early Mortality and Failure to Control Bleeding

  2001cited by this paper
• Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage.

  2001cited by this paper
• Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

  2001cited by this paper
• Comparative study of bacterial infection prevalence between cirrhotic patients with and without upper gastrointestinal bleeding.

  2001cited by this paper
• A meta‐analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding

  2001cited by this paper
• Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?

  2001cited by this paper
• Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.

  2001cited by this paper
• Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: Extended follow-up of an expanded randomized prospective trial

  2000cited by this paper
• A prospective randomized trial between the prophylactic endoscopicvariceal ligation and propranolol administration for prevention offirst bleeding in cirrhotic patients with high-risk esophageal varices

  2000cited by this paper
• Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension

  2000cited by this paper
• Initial report of a randomized, prospective study of prophylactic propranolol compared to rubber band ligation for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices

  2000cited by this paper
• Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.

  2000cited by this paper
• Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST Study

  2000cited by this paper
• Lack of an antifibrotic effect of the mixed endothelin A/B receptorantagonist LU 420627 on rat secondary biliary fibrosis in rats

  2000cited by this paper
• Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis

  2000cited by this paper
• Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

  2000cited by this paper
• Cost‐effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding

  2000cited by this paper
• Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized Trial

  2000cited by this paper
• Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis

  1999cited by this paper
• Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.

  1999cited by this paper
• Predictors of large esophageal varices in patients with cirrhosis

  1999cited by this paper
• Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.

  1999cited by this paper
• Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta‐analysis

  1999cited by this paper
• Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis

  1999cited by this paper
• Bacterial infection in the pathogenesis of variceal bleeding.

  1999cited by this paper
• For Pancreatitis in Inflammatory Bowel Disease, Treat the Bowel

  1999cited by this paper
• TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.

  1999cited by this paper
• Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension.

  1999cited by this paper
• Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.

  1999cited by this paper
• Endoscopic Treatments for Portal Hypertension

  1999cited by this paper
• A predictive model for failure to control bleeding during acute variceal haemorrhage.

  1999cited by this paper
• Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: A prospective randomized trial

  1999cited by this paper
• Cost analysis for the prevention of variceal rebleeding: A comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of italian cirrhotic patients

  1999cited by this paper
• Non-invasive diagnosis of esophageal varices in chronic liver diseases.

  1999cited by this paper
• Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach

  1999cited by this paper
• Oxford Textbook of Clinical Hepatology

  1999cited by this paper
• Predictors of large esophageal varices in patients with cirrhosis.

  1999cited by this paper
• Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for esophageal varices

  1998cited by this paper
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.

  1998cited by this paper
• ‘De novo’ development of esophageal varices in patients with a recent histologic diagnosis of liver cirrhosis

  1998cited by this paper
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis

  1998cited by this paper
• Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding.

  1997cited by this paper
• Beta‐adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta‐analysis

  1997cited by this paper
• Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high‐risk esophageal varices

  1997cited by this paper
• Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis.

  1997cited by this paper
• Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.

  1997cited by this paper
• Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.

  1997cited by this paper
• Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial.

  1997cited by this paper
• Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis

  1996cited by this paper
• Portal hypertension II : proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies

  1996cited by this paper
• Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)

  1996cited by this paper
• Octreotide vs. sclerotherapy and octreotide for acute variceal bleeding. A pilot study

  1996cited by this paper
• A randomized controlled trial of endoscopie variceal band ligation for primary prophylaxis of variceal bleeding

  1996cited by this paper
• Developing consensus in portal hypertension.

  1996cited by this paper
• Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.

  1996cited by this paper
• Developing consensus in portal hypertension

  1996cited by this paper
• Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients.

  1995cited by this paper
• Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.

  1995cited by this paper
• The treatment of portal hypertension: A meta‐analytic review

  1995cited by this paper
• Interobserver and interquipment variability of echo‐doppler examination of the portal vein: Effect of a cooperative training program

  1995cited by this paper
• A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage.

  1995cited by this paper
• First bleeding episode from oesophageal varices in cirrhotic patients: a prospective study of endoscopic predictive factors.

  1995cited by this paper
• Sclerotherapy with or without octreotide for acute variceal bleeding.

  1995cited by this paper
• Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.

  1995cited by this paper
• Vasoconstrictors in the management of bleeding from oesophageal varices. A clinico-economic appraisal in the UK.

  1995cited by this paper
• Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation.

  1995cited by this paper
• Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.

  1993cited by this paper

• The Utility of Platelet Count to Spleen Bipolar Length Ratio as a Noninvasive Parameter for the Diagnosis of Esophageal Varices in Liver Cirrhosis

  2026cites this paper
• Porto Sinusoidal Vascular Disorder: A Case Report

  2025cites this paper
• Cost effectiveness of esophageal varices screening strategies of cirrhotic patients with portal hypertension

  2024cites this paper
• Nomogram-based prediction of portal vein system thrombosis formation after splenectomy in patients with hepatolenticular degeneration

  2023cites this paper
• Diagnostic validity of serum YKL-40 as a non-invasive diagnostic marker of oesophageal varices in cirrhotic hepatitis C virus patients

  2022cites this paper
• Comparison of portal hypertensive gastropathy and gastric antral vascular ectasia: an update

  2022cites this paper
• Brief Review of Portal Hypertension Related Complications

  2021cites this paper
• Endoscopic Treatment of Esophageal Varices: Selection of Treatment Method

  2019cites this paper
• Vascular Disorders in the Liver

  2019cites this paper
• Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients

  2017cites this paper
• The Principles of primary prophylaxis of bleeding from oesophagealvaricies in patients with liver cirrhosis.

  2016cites this paper
• Comparison of effects of devascularization versus shunt on patients with portal hypertension: a meta-analysis.

  2015cites this paper
• MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.

  2015cites this paper
• Effects of selective double portazygous disconnection and devascularization on hemodynamics of the portal venous system.

  2015cites this paper
• Chapter 36 – Monitoring and Care

  2014cites this paper
• Oesophageal capsule endoscopy versus oesophago-gastroduodenoscopy for the diagnosis of recurrent varices: a prospective multicentre study.

  2014cites this paper
• Evaluation on therapeutic effects of orthotopic liver transplantation by megnetic resonance imaging in patients with portal hypertension.

  2014cites this paper
• Selective double disconnection for cirrhotic portal hypertension.

  2014cites this paper
• Laparoscopic splenectomy plus preoperative endoscopic variceal ligation versus splenectomy with pericardial devascularization (Hassab’s operation) for control of severe varices due to portal hypertension

  2013cites this paper
• Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.

  2012cites this paper
• Is pregnancy safe with extrahepatic portal vein obstruction? An analysis.

  2012cites this paper
• Prediction and screening of esophageal varices in cirrhotic patients using doppler US hemodynamic indices of portal system

  2011cites this paper
• Esophageal Capsule Endoscopy for Screening Esophageal Varices among Japanese Patients with Liver Cirrhosis

  2011cites this paper
• A Propósito de um Caso de Cirrose Hepática.

  2010cites this paper
• Cirrhosis of the Liver and Its Complications

  2010cites this paper
• Chapter 41 – Portal Hypertension and Esophageal Varices

  2009cites this paper
• Management of Variceal Hemorrhage

  2009cites this paper
• Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins

  2009cites this paper
• Meta-analysis of capsule endoscopy in patients diagnosed or suspected with esophageal varices.

  2009cites this paper
• Acrylate glue injection for acutely bleeding oesophageal varices: A prospective cohort study.

  2009cites this paper
• Liver cirrhosis.

  2008cites this paper
• Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis.

  2008cites this paper
• Preventing a first episode of esophageal variceal hemorrhage.

  2008cites this paper
• Nitric oxide levels in chronic liver disease patients with and without oesophageal varices

  2008cites this paper
• Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment

  2007cites this paper
• Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C.

  2007cites this paper
• Transient elastography for diagnosis of portal hypertension in liver cirrhosis: Is there still a role for hepatic venous pressure gradient measurement?

  2007cites this paper
• Splenectomy with endoscopic variceal ligation is superior to splenectomy with pericardial devascularization in treatment of portal hypertension.

  2006cites this paper
• Esophageal Capsule Endoscopy versus Esophagogastroduodenoscopy for Evaluating Portal Hypertension: a Prospective Comparative Study of Performance and Tolerance

  2006cites this paper
• Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.

  2006cites this paper
• Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up.

  2005cites this paper
• Treatment of variceal bleeding in patients with cirrhosis of the liver

  2005cites this paper